Subscribe
Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

JAMA Editor’s Summary

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue
July 1, 2014
ADVERTISEMENT
Wise-Formerly Transferwise

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue

ADVERTISEMENT
WP Engine Wordpress Hosting

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.